Document And Entity Information
Document And Entity Information - shares | 6 Months Ended | |
Dec. 31, 2018 | Feb. 01, 2019 | |
Document Information [Line Items] | ||
Entity Registrant Name | BION ENVIRONMENTAL TECHNOLOGIES INC | |
Entity Central Index Key | 875,729 | |
Trading Symbol | bnet | |
Current Fiscal Year End Date | --06-30 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Current Reporting Status | Yes | |
Entity Emerging Growth Company | false | |
Entity Small Business | true | |
Entity Common Stock, Shares Outstanding (in shares) | 26,819,980 | |
Document Type | 10-Q | |
Document Period End Date | Dec. 31, 2018 | |
Document Fiscal Year Focus | 2,019 | |
Document Fiscal Period Focus | Q2 | |
Amendment Flag | false |
Consolidated Balance Sheets (Cu
Consolidated Balance Sheets (Current Period Unaudited) - USD ($) | Dec. 31, 2018 | Jun. 30, 2018 |
Current assets: | ||
Cash | $ 42,321 | $ 22,013 |
Prepaid expenses | 1,608 | 7,474 |
Deposits and other receivables | 1,000 | 1,000 |
Total current assets | 44,929 | 30,487 |
Property and equipment, net (Note 3) | 1,711 | 1,448 |
Total assets | 46,640 | 31,935 |
Current liabilities: | ||
Accounts payable and accrued expenses | 643,707 | 719,633 |
Deferred compensation (Note 4) | 698,766 | 421,641 |
Loan payable and accrued interest (Note 5) | 9,160,313 | 9,028,983 |
Total current liabilities | 10,535,186 | 10,201,657 |
Convertible notes payable - affiliates (Note 6) | 3,588,130 | 3,525,216 |
Total liabilities | 14,123,316 | 13,726,873 |
Deficit: | ||
Common stock, no par value, 100,000,000 shares authorized, 27,121,371 and 25,939,892 shares issued, respectively; 26,417,062 and 25,235,583 shares outstanding, respectively | ||
Additional paid-in capital | 109,507,489 | 108,117,330 |
Subscription receivable - affiliates (Note 7) | (504,650) | (174,650) |
Accumulated deficit | (123,130,161) | (121,691,956) |
Total Bion’s stockholders’ deficit | (14,127,322) | (13,749,276) |
Noncontrolling interest | 50,646 | 54,338 |
Total deficit | (14,076,676) | (13,694,938) |
Total liabilities and deficit | 46,640 | 31,935 |
Series B Preferred Stock [Member] | ||
Current liabilities: | ||
Series B Redeemable Convertible Preferred stock, $0.01 par value, 50,000 shares authorized; 200 shares issued and outstanding, liquidation preference of $35,000 and $34,000, respectively (Note 7) | 32,400 | 31,400 |
Series A Preferred Stock [Member] | ||
Deficit: | ||
Preferred stock | ||
Series C Preferred Stock [Member] | ||
Deficit: | ||
Preferred stock |
Consolidated Balance Sheets (_2
Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) | Dec. 31, 2018 | Jun. 30, 2018 |
Common stock, par value (in dollars per share) | $ 0 | $ 0 |
Common stock, authorized (in shares) | 100,000,000 | 100,000,000 |
Common stock, issued (in shares) | 27,121,371 | 25,939,892 |
Common stock, outstanding (in shares) | 26,417,062 | 25,235,583 |
Series B Preferred Stock [Member] | ||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, authorized (in shares) | 50,000 | 50,000 |
Preferred stock, issued (in shares) | 200 | 200 |
Preferred stock, outstanding (in shares) | 200 | 200 |
Preferred stock, liquidation | $ 35,000 | $ 34,000 |
Series A Preferred Stock [Member] | ||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, authorized (in shares) | 50,000 | 50,000 |
Preferred stock, issued (in shares) | 0 | 0 |
Preferred stock, outstanding (in shares) | 0 | 0 |
Series C Preferred Stock [Member] | ||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, authorized (in shares) | 60,000 | 60,000 |
Preferred stock, issued (in shares) | 0 | 0 |
Preferred stock, outstanding (in shares) | 0 | 0 |
Consolidated Statements of Oper
Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | |
Revenue | ||||
Operating expenses: | ||||
General and administrative (including stock-based compensation (Note 7)) | 289,599 | 808,576 | 967,489 | 1,120,693 |
Depreciation | 259 | 436 | 695 | 872 |
Research and development (including stock-based compensation (Note 7)) | 114,192 | 338,755 | 283,913 | 445,501 |
Total operating expenses | 404,050 | 1,147,767 | 1,252,097 | 1,567,066 |
Loss from operations | (404,050) | (1,147,767) | (1,252,097) | (1,567,066) |
Other expense (income): | ||||
Gain on extinguishment of liabilities | (718,580) | (718,580) | ||
Interest expense | 97,304 | 93,662 | 189,800 | 192,101 |
Total other expense (income) | 97,304 | (624,918) | 189,800 | (526,479) |
Net loss | (501,354) | (522,849) | (1,441,897) | (1,040,587) |
Net loss attributable to the noncontrolling interest | 523 | 507 | 3,692 | 1,014 |
Net loss applicable to Bion's common stockholders | $ (500,831) | $ (522,342) | $ (1,438,205) | $ (1,039,573) |
Net loss applicable to Bion's common stockholders per basic and diluted common share (in dollars per share) | $ (0.02) | $ (0.02) | $ (0.06) | $ (0.04) |
Weighted-average number of common shares outstanding: Basic and diluted (in shares) | 26,382,778 | 24,233,123 | 26,021,254 | 24,150,108 |
Consolidated Statements of Chan
Consolidated Statements of Changes in Equity (Deficit) (Unaudited) - 6 months ended Dec. 31, 2018 - USD ($) | Preferred Stock [Member]Series A Preferred Stock [Member] | Preferred Stock [Member]Series C Preferred Stock [Member] | Common Stock [Member] | Additional Paid-in Capital [Member] | Subscriptions Receivable [Member] | Retained Earnings [Member] | Noncontrolling Interest [Member] | Total |
Balances (in shares) at Jun. 30, 2018 | 25,939,892 | |||||||
Balances at Jun. 30, 2018 | $ 108,117,330 | $ (174,650) | $ (121,691,956) | $ 54,338 | $ (13,694,938) | |||
Issuance of common stock for services (in shares) | 25,718 | |||||||
Issuance of common stock for services | 13,904 | 13,904 | ||||||
Vesting of options for services | 118,000 | 118,000 | ||||||
Modification of options | 222,300 | 222,300 | ||||||
Sale of units (in shares) | 954,733 | |||||||
Sale of units | 477,365 | $ 477,365 | ||||||
Commissions on sale of units (in shares) | 1,028 | 1,028 | ||||||
Commissions on sale of units | (44,436) | $ (44,436) | ||||||
Modification of warrants | 166,776 | 166,776 | ||||||
Issuance of warrants | 336,250 | (330,000) | 6,250 | |||||
Conversion of debt and liabilities (in shares) | 200,000 | |||||||
Conversion of debt and liabilities | 100,000 | 100,000 | ||||||
Net loss | (1,438,205) | (3,692) | (1,441,897) | |||||
Balances (in shares) at Dec. 31, 2018 | 27,121,371 | |||||||
Balances at Dec. 31, 2018 | $ 109,507,489 | $ (504,650) | $ (123,130,161) | $ 50,646 | $ (14,076,676) |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 6 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Net loss | $ (1,441,897) | $ (1,040,587) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation expense | 695 | 872 |
Accrued interest on loan payable, deferred compensation and other | 203,632 | 209,684 |
Stock-based compensation | 527,230 | 819,698 |
Gain on extinguishment of liabilities | (718,580) | |
Decrease in prepaid expenses | 5,866 | 5,691 |
(Decrease) increase in accounts payable and accrued expenses | (62,989) | 68,102 |
Increase in deferred compensation | 355,800 | 406,800 |
Net cash used in operating activities | (411,663) | (248,320) |
CASH FLOWS FROM INVESTING ACTIVITIES | ||
Purchase of property and equipment | (958) | |
Net cash used in investing activities | (958) | |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Proceeds from sale of units | 477,365 | 186,832 |
Commissions on sale of units | (44,436) | (13,508) |
Proceeds from loans payable - affiliates | 30,500 | |
Net cash provided by financing activities | 432,929 | 203,824 |
Net increase (decrease) in cash | 20,308 | (44,496) |
Cash at beginning of period | 22,013 | 72,932 |
Cash at end of period | 42,321 | 28,436 |
Supplemental disclosure of cash flow information: | ||
Cash paid for interest | ||
Non-cash investing and financing transactions: | ||
Purchase of warrants for subscription receivable - affiliates | 330,000 | 134,650 |
Conversion of debt and liabilities | 100,000 | |
Shares issued for warrant exercise commissions | 514 | |
Warrants issued for unit commissions | 4,850 | |
Forgiveness of deferred compensation - related parties | $ 1,685,252 |
Note 1 - Organization, Nature o
Note 1 - Organization, Nature of Business, Going Concern and Management's Plans | 6 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] | 1. Organization and nature of business: Bion Environmental Technologies, Inc. (“Bion” or “We” or the “Company”) was incorporated in 1987 third third From 2014 2019 third “3G 2019 no may 3G 2 For the past decade, Bion has been directed toward creating applications of our patented and proprietary waste management technologies and technology platform to pursue JVs in three 1 Installation of Bion systems to retrofit and environmentally remediate existing large CAFOs (“Retrofits” and “Retrofit Projects”) in selected markets where: a) government policy supports such efforts (such as the Chesapeake Bay watershed, Great Lakes Basin states, and/or other states and watersheds facing EPA ‘total maximum daily load’ (“TMDL”) issues), and/or b) CAFO’s need our technology to obtain permits to expand or develop without negative environmental consequences. 2 3G may one may 3G 3 In both categories 1 2 The opportunities described at 1 2 At this time, our primary focus is on category 2 3G 2 3G may During 2008 first 1 2011. January 26, 2009 $7.75 1, “PA1” 1 August 12, 2010 PA1 1 November 2010. November 3, 2010. PA1 1 May 2011. 1 2012 2011 1 August 1, 2012 1 PA1 1 PA1’s 1 PA1 1 PA1 1 PA1 four PA1 not January 2013. not 2013, December 31, 2018. three 1 PA1 1 $3,750,000 June 30, 2015. 2016 PA1 $1,684,562 1 1 PA1’s 1 1 On September 25, 2014, PA1 $8,137,117 October 24, 2014. PA1 not not PA1 PA1’s 2014. No 48 not 1 may no PA1 1 30 180 During August 2012, 1 PA1 The economics (potential revenues, profitability and continued operation) of the Kreider 1 On May 5, 2016, PA2 “PA2” 2” The Kreider projects are owned and operated by Bion through separate subsidiaries, in which Kreider has the option to acquire a noncontrolling interest. Substantial capital (equity and/or debt) has been and will continue to be expended on these projects. Additional funds will be required for continuing operations and additional capital expenditures for upgrades at Kreider 1 no 1 1 Kreider Farms – 3G Bion is completing an envelope of policy change and technology pilots that will allow it to move forward with the first 3G 3G two 2019 2 2019: 1. 799 2 2 2. 3G The 3G 2 two 1,800 six million three million 450 three may Bion has a long-standing relationship with Kreider Farms including a 2016 SB799 2. may 6 SB799 2 2019. Assuming there are positive developments related to the market for nutrient reductions in Pennsylvania, the Company intends to pursue development, design and construction of the Kreider 2 2019. Bion’s current long-term goal is to acquire or develop, or have in a development pipeline, 6 12 36 48 A significant portion of Bion’s activities concern efforts with private and public stakeholders (at local and state level) in Pennsylvania (and other Chesapeake Bay and Midwest and Great Lakes states) and at the federal level EPA and the Department of Agriculture (“USDA”) (and other executive departments) and Congress) to establish appropriate public policies which will create regulations and funding mechanisms that foster installation of the low cost environmental solutions that Bion (and others) can provide through clean-up of agricultural waste streams. The Company anticipates that such efforts will continue in Pennsylvania and other Chesapeake Bay watershed states throughout the next 12 Going concern and management’s plans: The consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has not $3,018,000 $2,463,000 June 30, 2018 2017, $1,442,000 six December 31, 2018. December 31, 2018, $10,490,000 $14,127,000, not may The Company continues to explore sources of additional financing (including potential agreements with strategic partners – both financial and ag-industry) to satisfy its current and future operating and capital expenditure requirements as it is not During the years ended June 30, 2018 2017, $418,000 $452,000 2018 2017 During the six December 31, 2018, $477,000 $44,000 During fiscal years 2018 2017, 4 6 June 30, 2018, one $2,404,000. June 30, 2014 2015 June 30, 2018. not 1 The Company will need to obtain additional capital to fund its operations and technology development, to satisfy existing creditors, to develop Projects (including Integrated Projects and the Kreider 2 1 $2,500,000 $50,000,000 twelve no There is no twelve no not |
Note 2 - Significant Accounting
Note 2 - Significant Accounting Policies | 6 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Significant Accounting Policies [Text Block] | 2. Principles of consolidation: The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Bion Integrated Projects Group, Inc. (“Projects Group”), Bion Technologies, Inc., BionSoil, Inc., Bion Services, PA1, PA2; 58.9% The accompanying consolidated financial statements have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The consolidated financial statements reflect all adjustments (consisting of only normal recurring entries) that, in the opinion of management, are necessary to present fairly the financial position at December 31, 2018, three six December 31, 2018 2017. three six December 31, 2018 not may June 30, 2019. Cash and cash equivalents: The Company considers all highly liquid investments purchased with an original maturity of three Property and equipment: Property and equipment are stated at cost and are depreciated, when placed into service, using the straight-line method over the estimated useful lives of the related assets, generally three twenty no no may not Stock-based compensation: The Company follows the provisions of Accounting Standards Codification (“ASC”) 718, Derivative Financial Instruments: Pursuant to ASC Topic 815 815” may Warrants: The Company has issued warrants to purchase common shares of the Company. Warrants are valued using a fair value based method, whereby the fair value of the warrant is determined at the warrant issue date using a market-based option valuation model based on factors including an evaluation of the Company’s value as of the date of the issuance, consideration of the Company’s limited liquid resources and business prospects, the market price of the Company’s stock in its mostly inactive public market and the historical valuations and purchases of the Company’s warrants. When warrants are issued in combination with debt or equity securities, the warrants are valued and accounted for based on the relative fair value of the warrants in relation to the total value assigned to the debt or equity securities and warrants combined. Concentrations of credit risk: The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times may not Noncontrolling interests: In accordance with ASC 810, Fair value measurements: Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or most advantageous market. The Company uses a fair value hierarchy that has three Level 1 Level 2 1, not Level 3 Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company’s market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may The fair value of cash and accounts payable approximates their carrying amounts due to their short-term maturities. The fair value of the loan payable is indeterminable at this time due to the nature of the arrangement with a state agency and the fact that it is in default. The fair value of the redeemable preferred stock approximates its carrying value due to the dividends accrued on the preferred stock which are reflected as part of the redemption value. The fair value of the deferred compensation and convertible notes payable - affiliates are not Revenue Recognition: The Company currently does not 606 Loss per share: Basic loss per share amounts are calculated using the weighted average number of shares of common stock outstanding during the period. Diluted loss per share assumes the conversion, exercise or issuance of all potential common stock instruments, such as options or warrants, unless the effect is to reduce the loss per share or increase the earnings per share. During the three six December 31, 2018 2017, The following table represents the warrants, options and convertible securities excluded from the calculation of basic loss per share: December 31, 2018 December 31, 2017 Warrants 16,305,320 12,195,920 Options 7,152,225 4,840,037 Convertible debt 8,136,018 6,855,942 Convertible preferred stock 17,500 16,500 The following is a reconciliation of the denominators of the basic and diluted loss per share computations for the three six December 31, 2018 2017: Three months ended December 31, 2018 Three months ended December 31, 2017 Six months ended December 31, 2018 Six months ended December 31, 2017 Shares issued – beginning of period 26,996,148 24,809,841 25,939,892 24,748,213 Shares held by subsidiaries (Note 7) (704,309 ) (704,309 ) (704,309 ) (704,309 ) Shares outstanding – beginning of period 26,291,839 24,105,532 25,235,583 24,043,904 Weighted average shares issued during the period 90,939 127,591 785,681 106,204 Diluted weighted average shares – end of period 26,382,778 24,233,123 26,021,264 24,150,108 Use of estimates: In preparing the Company’s consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Recent Accounting Pronouncements: The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company’s financial reporting, the Company undertakes a study to determine the consequences of the change to its financial statements and assures that there are proper controls in place to ascertain that the Company’s financial statements properly reflect the change. In May 2017, No. 2017 09 No. 2017 09 December 15, 2017, 2017 09 not |
Note 3 - Property and Equipment
Note 3 - Property and Equipment | 6 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Property, Plant and Equipment Disclosure [Text Block] | 3. Property and equipment consists of the following: December 31, 2018 June 30, 2018 Machinery and equipment $ 2,222,670 $ 2,222,670 Buildings and structures 401,470 401,470 Computers and office equipment 171,720 171,613 2,795,860 2,795,753 Less accumulated depreciation (2,794,149 ) (2,794,305 ) $ 1,711 $ 1,448 Management reviewed property and equipment for impairment as of June 30, 2016 1 1 3 $1,684,562 June 30, 2016. June 30, 2016, 1 zero December 31, 2018, no Depreciation expense was $259 $436 three December 31, 2018 2017, $695 $872 six December 31, 2018 2017, |
Note 4 - Deferred Compensation
Note 4 - Deferred Compensation | 6 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | 4. The Company owes deferred compensation to various employees, former employees and consultants totaling $698,766 $141,284 December 31, 2018 2017, December 31, 2018, $396,041 $42,541 January 1, 2015, January 1, 2015, 4% first five 10 December 31, 2017 $31,000 $18,000, $186,700 $18,800 December 31, 2018 2017, 3% $300,000 $0.75 December 31, 2019 ( 2006 2006 no $984 1,427 December 31, 2018 $72,500, not The Company recorded interest expense of $8,388 $6,596 $31,055 $25,177 six December 31, 2018 2017, |
Note 5 - Loan Payable
Note 5 - Loan Payable | 6 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Debt Disclosure [Text Block] | 5. PA1, $9,160,313 December 31, 2018 1 $1,406,313 December 31, 2018. $7,754,000 three ten 2.547% 1 5 3.184% 6 $3,502,000 2013 2018, $771,000 2019, $794,000 2020, $819,000 2021, $846,000 2022, $873,000 2023 $149,000 1 1 not 1 $60,408 $49,373 three December 31, 2018 2017, $113,747 $98,747 six December 31, 2018 December 31, 2017, PA1 PA1 not January 2013. not 2013, December 31, 2018. On September 25, 2014, PA1 $8,137,117 October 24, 2014. PA1 not not PA1 no no 48 not may PA1 1 30 180 In connection with the Pennvest Loan financing documents, the Company provided a ‘technology guaranty’ regarding nutrient reduction performance of Kreider 1 1’s August 2012 1 PA1. |
Note 6 - Convertible Notes Paya
Note 6 - Convertible Notes Payable - Affiliates | 6 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Convertible Debt [Text Block] | 6. January 2015 The January 2015 4% December 31, 2017. June 30, 2017, January 2015 July 1, 2019 July 1, 2021 September 30, 2018. January 2015 one one $0.50 December 31, 2020. $1.00 December 31, 2020. $0.50 no 815 15 not not not 815 10, As of December 31, 2018, January 2015 $1,698,873, $882,202 $438,816, December 31, 2017, January 2015 $1,640,291, $851,781 $423,685, January 2015 $26,247 three December 31, 2018 2017, $52,495 six December 31, 2018 2017, During the six December 31, 2018, 3,000,000 300,000 $0.60 June 30, 2025 June 30, 2023, $0.10 $300,000 $30,000 January 2015 7 September 2015 During the year ended June 30, 2016, September 2015 September 2015 $405,831, $16,382 $82,921, September 2015 4% December 31, 2017 may $0.60 $0.60 September 2015 no June 30, 2018, September 2015 two $130,000, six December 31, 2018, $300,000 second The balances of the September 2015 December 31, 2018, $157,141, $18,554 $392,544, September 2015 December 31, 2017, $443,627, $17,899 $90,600, Effective June 30, 2017, September 2015 July 1, 2019 June 30, 2018, July 1, 2019. six December 31, 2018, September 2015 July 1, 2021. The Company recorded interest expense of $5,410 $5,308 three December 31, 2018 2017, $10,420 $10,401 six December 31, 2018 2017, |
Note 7 - Stockholders' Equity
Note 7 - Stockholders' Equity | 6 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Stockholders' Equity Note Disclosure [Text Block] | 7. Series B Preferred stock: At July 1, 2014, 200 $0.01 $2.00 2.5% $100 three 200 not During the years ended June 30, 2018 2017, $2,000 $2,000 six December 31, 2018, $1,000. December 31, 2018, $15,000. Common stock: Holders of common stock are entitled to one no may may Centerpoint holds 704,309 During the six December 31, 2018, 25,718 $0.50 $0.74 $13,904, During the six December 31, 2018, 1,028 June 30, 2018 $514. During the six December 31, 2018, two $0.50 one one one $0.75 June 30, 2019 954,733 $477,365, $432,929 954,733 477,369 $0.05 $17,515 $459,850 During the six December 31, 2018, $87,063 $12,937, 200,000 $0.50 one one one $0.75 December 31, 2022. Warrants: As of December 31, 2018, 16.3 $0.60 $3.00 June 30, 2025. The weighted-average exercise price for the outstanding warrants is $0.96, December 31, 2018 4.1 During the six December 31, 2018, 41,319 $1.00 During the six December 31, 2018, two $0.50 one one one $0.75 June 30, 2019 954,733 $477,365, $432,932 954,733 477,369 $0.05 $17,515 $459,850 During the six December 31, 2018, $300,000 3,000,000 $0.60 December 31, 2025. 4% January 2015 July 1, 2020. During the six December 31, 2018, $30,000 300,000 $0.60 December 31, 2023. 75% 4% 2015 January 2015 July 1, 2020. During the six December 31, 2018, $87,063 $12,937, 200,000 $0.50 one one one $0.75 December 31, 2022. During the six December 31, 2018, 125,000 125,000 $0.74 $1.20 August 27, 2020 October 27, 2020. $6,250, During the six December 31, 2018, 5,079,188 1,765,000 3,104,010 September 30, 2018 December 31, 2021. $163,026 $88,250 $68,758 $3,750 Stock options: The Company’s 2006 “2006 30,000,000 2006 may no may ten During the six December 31, 2018, $222,300. The Company recorded compensation expense related to employee stock options of $22,500 $97,350 three December 31, 2018 2017, $118,000 $99,650 six December 31, 2018 2017, 325,000 295,000 six December 31, 2018 2017, The fair value of the options granted during the six December 31, 2018 2017 Weighted Average, December 31, 2018 Range, December 31, 2018 Weighted Average, December 31, 2017 Range, December 31, 2017 Volatility 70% 63% - 76% 73% 73% Dividend yield - - - - Risk-free interest rate 2.73% 2.68% - 2.78% 1.75% 1.75% Expected term (years) 3.9 3.4 to 4.3 3 3 The expected volatility was based on the historical price volatility of the Company’s common stock. The dividend yield represents the Company’s anticipated cash dividend on common stock over the expected term of the stock options. The U.S. Treasury bill rate for the expected term of the stock options was utilized to determine the risk-free interest rate. The expected term of stock options represents the period of time the stock options granted are expected to be outstanding based upon management’s estimates. A summary of option activity under the 2006 six December 31, 2018 Options Weighted- Average Exercise Price Weighted- Average Remaining Contractual Life Aggregate Intrinsic Value Outstanding at July 1, 2018 6,827,225 $ 1.11 3.8 $ - Granted 325,000 0.68 Exercised - - Forfeited - - Expired - - Outstanding at December 31, 2018 7,152,225 $ 1.10 3.5 $ 36,675 Exercisable at December 31, 2018 7,002,225 $ 1.11 3.6 $ 23,175 The following table presents information relating to nonvested stock options as of December 31, 2018: Options Weighted Average Grant-Date Fair Value Nonvested at July 1, 2018 - $ - Granted 325,000 0.36 Vested (175,000 ) 0.46 Nonvested at December 31, 2018 150,000 $ 0.25 The total fair value of stock options that vested during the six December 31, 2018 2017 $80,500 nil December 31, 2018, no Stock-based employee compensation charges in operating expenses in the Company’s financial statements for the three six December 31, 2018 2017 Three months ended December 31, 2018 Three months ended December 31, 2017 Six months ended December 31, 2018 Six months ended December 31, 2017 General and administrative: Fair value of stock bonuses expensed $ - $ 3,090 $ - $ 7,223 Change in fair value from modification of option terms - 243,761 211,185 243,761 Change in fair value from modification of warrant terms - 156,865 118,233 156,865 Fair value of stock options expensed 22,500 97,350 92,125 99,650 Total $ 22,500 $ 501,066 $ 421,543 $ 507,499 Research and development: Fair value of stock bonus expensed $ - $ 8,071 $ - $ 15,098 Change in fair value from modification of option terms - 105,895 11,115 105,895 Change in fair value from modification of warrant terms - 132,677 44,793 132,677 Fair value of stock options expensed - - 25,875 - Total $ - $ 246,643 $ 81,783 $ 253,670 |
Note 8 - Commitments and Contin
Note 8 - Commitments and Contingencies | 6 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Commitments and Contingencies Disclosure [Text Block] | 8. Employment and consulting agreements: Smith has held the positions of Director, President and General Counsel of Company and its subsidiaries under various agreements and terms since March 2003. March 2003. October 10, 2016, $18,000 October 1, 2016 $125,000 $0.75 March 15, 2018 ( April 27, 2017 $300,000 $0.75 December 31, 2019), third July 29, 2018 Since March 31, 2005, May 13, 2011. February 10, 2015, December 31, 2017, ( six $31,000 October 2016 $125,000 $0.75 March 15, 2018 ( April 27, 2017 $300,000 $0.75 December 31, 2019). February 2018, two $372,000 $2,000 August 1, 2018, December 31, 2022) 2 $300,000 3,000,000 $0.60 June 30, 2025. $300,000 January 2015 6 7 Execution/exercise bonuses: As part of agreements the Company entered into with Bassani and Smith effective May 15, 2013, 50% 50% five one $.05 three three January 1, 2016 $.01 During the year ended June 30, 2014, 50% During the year ended June 30, 2018, 50% November 7, 2017, two During the year ended June 30, 2018, 50% 75% 75% As of December 31, 2018, 50 90% 6,959,600 12,032,095 Litigation: On September 25, 2014, PA1 $8,137,117 October 24, 2014. PA1 not not August 2012, 1 PA1. No not 1 5 The Company currently is not |
Note 9 - Related Party Transact
Note 9 - Related Party Transactions | 6 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Related Party Transactions Disclosure [Text Block] | 9. The Coalition for Affordable Bay Solutions (“CABS”), a not June 30, 2017 $165,650 $68,900 129,000 $96,750 third June 30, 2018, $41,000 During the three six December 31, 2018, nil $30,000 no three six December 31, 2017. 16,000 $8,000 third six December 31, 2018, no six December 31, 2017. During the six December 31, 2018, not June 30, 2018 2017. not |
Note 10 - Subsequent Events
Note 10 - Subsequent Events | 6 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Subsequent Events [Text Block] | 10. The Company has evaluated events that occurred subsequent to December 31, 2018 From January 1, 2019 February 6, 2019, 2,918 $2,000. From January 1, 2019 February 6, 2019, 400,000 $0.50 $200,000. one $0.75 December 31, 2020. |
Significant Accounting Policies
Significant Accounting Policies (Policies) | 6 Months Ended |
Dec. 31, 2018 | |
Accounting Policies [Abstract] | |
Consolidation, Policy [Policy Text Block] | Principles of consolidation: The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Bion Integrated Projects Group, Inc. (“Projects Group”), Bion Technologies, Inc., BionSoil, Inc., Bion Services, PA1, PA2; 58.9% The accompanying consolidated financial statements have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The consolidated financial statements reflect all adjustments (consisting of only normal recurring entries) that, in the opinion of management, are necessary to present fairly the financial position at December 31, 2018, three six December 31, 2018 2017. three six December 31, 2018 not may June 30, 2019. |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash and cash equivalents: The Company considers all highly liquid investments purchased with an original maturity of three |
Property, Plant and Equipment, Policy [Policy Text Block] | Property and equipment: Property and equipment are stated at cost and are depreciated, when placed into service, using the straight-line method over the estimated useful lives of the related assets, generally three twenty no no may not |
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] | Stock-based compensation: The Company follows the provisions of Accounting Standards Codification (“ASC”) 718, |
Derivatives, Policy [Policy Text Block] | Derivative Financial Instruments: Pursuant to ASC Topic 815 815” may |
Equity Issuances Warrants Policy [Policy Text Block] | Warrants: The Company has issued warrants to purchase common shares of the Company. Warrants are valued using a fair value based method, whereby the fair value of the warrant is determined at the warrant issue date using a market-based option valuation model based on factors including an evaluation of the Company’s value as of the date of the issuance, consideration of the Company’s limited liquid resources and business prospects, the market price of the Company’s stock in its mostly inactive public market and the historical valuations and purchases of the Company’s warrants. When warrants are issued in combination with debt or equity securities, the warrants are valued and accounted for based on the relative fair value of the warrants in relation to the total value assigned to the debt or equity securities and warrants combined. |
Concentration Risk, Credit Risk, Policy [Policy Text Block] | Concentrations of credit risk: The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times may not |
Minority Interest Policy [Policy Text Block] | Noncontrolling interests: In accordance with ASC 810, |
Fair Value Measurement, Policy [Policy Text Block] | Fair value measurements: Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or most advantageous market. The Company uses a fair value hierarchy that has three Level 1 Level 2 1, not Level 3 Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company’s market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may The fair value of cash and accounts payable approximates their carrying amounts due to their short-term maturities. The fair value of the loan payable is indeterminable at this time due to the nature of the arrangement with a state agency and the fact that it is in default. The fair value of the redeemable preferred stock approximates its carrying value due to the dividends accrued on the preferred stock which are reflected as part of the redemption value. The fair value of the deferred compensation and convertible notes payable - affiliates are not |
Revenue Recognition, Policy [Policy Text Block] | Revenue Recognition: The Company currently does not 606 |
Earnings Per Share, Policy [Policy Text Block] | Loss per share: Basic loss per share amounts are calculated using the weighted average number of shares of common stock outstanding during the period. Diluted loss per share assumes the conversion, exercise or issuance of all potential common stock instruments, such as options or warrants, unless the effect is to reduce the loss per share or increase the earnings per share. During the three six December 31, 2018 2017, The following table represents the warrants, options and convertible securities excluded from the calculation of basic loss per share: December 31, 2018 December 31, 2017 Warrants 16,305,320 12,195,920 Options 7,152,225 4,840,037 Convertible debt 8,136,018 6,855,942 Convertible preferred stock 17,500 16,500 The following is a reconciliation of the denominators of the basic and diluted loss per share computations for the three six December 31, 2018 2017: Three months ended December 31, 2018 Three months ended December 31, 2017 Six months ended December 31, 2018 Six months ended December 31, 2017 Shares issued – beginning of period 26,996,148 24,809,841 25,939,892 24,748,213 Shares held by subsidiaries (Note 7) (704,309 ) (704,309 ) (704,309 ) (704,309 ) Shares outstanding – beginning of period 26,291,839 24,105,532 25,235,583 24,043,904 Weighted average shares issued during the period 90,939 127,591 785,681 106,204 Diluted weighted average shares – end of period 26,382,778 24,233,123 26,021,264 24,150,108 |
Use of Estimates, Policy [Policy Text Block] | Use of estimates: In preparing the Company’s consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. |
New Accounting Pronouncements, Policy [Policy Text Block] | Recent Accounting Pronouncements: The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company’s financial reporting, the Company undertakes a study to determine the consequences of the change to its financial statements and assures that there are proper controls in place to ascertain that the Company’s financial statements properly reflect the change. In May 2017, No. 2017 09 No. 2017 09 December 15, 2017, 2017 09 not |
Note 2 - Significant Accounti_2
Note 2 - Significant Accounting Policies (Tables) | 6 Months Ended |
Dec. 31, 2018 | |
Notes Tables | |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] | December 31, 2018 December 31, 2017 Warrants 16,305,320 12,195,920 Options 7,152,225 4,840,037 Convertible debt 8,136,018 6,855,942 Convertible preferred stock 17,500 16,500 |
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] | Three months ended December 31, 2018 Three months ended December 31, 2017 Six months ended December 31, 2018 Six months ended December 31, 2017 Shares issued – beginning of period 26,996,148 24,809,841 25,939,892 24,748,213 Shares held by subsidiaries (Note 7) (704,309 ) (704,309 ) (704,309 ) (704,309 ) Shares outstanding – beginning of period 26,291,839 24,105,532 25,235,583 24,043,904 Weighted average shares issued during the period 90,939 127,591 785,681 106,204 Diluted weighted average shares – end of period 26,382,778 24,233,123 26,021,264 24,150,108 |
Note 3 - Property and Equipme_2
Note 3 - Property and Equipment (Tables) | 6 Months Ended |
Dec. 31, 2018 | |
Notes Tables | |
Property, Plant and Equipment [Table Text Block] | December 31, 2018 June 30, 2018 Machinery and equipment $ 2,222,670 $ 2,222,670 Buildings and structures 401,470 401,470 Computers and office equipment 171,720 171,613 2,795,860 2,795,753 Less accumulated depreciation (2,794,149 ) (2,794,305 ) $ 1,711 $ 1,448 |
Note 7 - Stockholders' Equity (
Note 7 - Stockholders' Equity (Tables) | 6 Months Ended |
Dec. 31, 2018 | |
Notes Tables | |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | Weighted Average, December 31, 2018 Range, December 31, 2018 Weighted Average, December 31, 2017 Range, December 31, 2017 Volatility 70% 63% - 76% 73% 73% Dividend yield - - - - Risk-free interest rate 2.73% 2.68% - 2.78% 1.75% 1.75% Expected term (years) 3.9 3.4 to 4.3 3 3 |
Share-based Compensation, Stock Options, Activity [Table Text Block] | Options Weighted- Average Exercise Price Weighted- Average Remaining Contractual Life Aggregate Intrinsic Value Outstanding at July 1, 2018 6,827,225 $ 1.11 3.8 $ - Granted 325,000 0.68 Exercised - - Forfeited - - Expired - - Outstanding at December 31, 2018 7,152,225 $ 1.10 3.5 $ 36,675 Exercisable at December 31, 2018 7,002,225 $ 1.11 3.6 $ 23,175 |
Schedule of Nonvested Share Activity [Table Text Block] | Options Weighted Average Grant-Date Fair Value Nonvested at July 1, 2018 - $ - Granted 325,000 0.36 Vested (175,000 ) 0.46 Nonvested at December 31, 2018 150,000 $ 0.25 |
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] | Three months ended December 31, 2018 Three months ended December 31, 2017 Six months ended December 31, 2018 Six months ended December 31, 2017 General and administrative: Fair value of stock bonuses expensed $ - $ 3,090 $ - $ 7,223 Change in fair value from modification of option terms - 243,761 211,185 243,761 Change in fair value from modification of warrant terms - 156,865 118,233 156,865 Fair value of stock options expensed 22,500 97,350 92,125 99,650 Total $ 22,500 $ 501,066 $ 421,543 $ 507,499 Research and development: Fair value of stock bonus expensed $ - $ 8,071 $ - $ 15,098 Change in fair value from modification of option terms - 105,895 11,115 105,895 Change in fair value from modification of warrant terms - 132,677 44,793 132,677 Fair value of stock options expensed - - 25,875 - Total $ - $ 246,643 $ 81,783 $ 253,670 |
Note 1 - Organization, Nature_2
Note 1 - Organization, Nature of Business, Going Concern and Management's Plans (Details Textual) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||||||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | Jun. 30, 2018 | Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | Sep. 25, 2014 | Jan. 26, 2009 | |
Construction Loan | $ 7,750,000 | |||||||||
Impairment of Long-Lived Assets Held-for-use | $ 1,684,562 | |||||||||
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total | $ (501,354) | $ (522,849) | $ (1,441,897) | $ (1,040,587) | $ (3,018,000) | $ (2,463,000) | ||||
Working Capital | 10,490,000 | 10,490,000 | ||||||||
Stockholders' Equity Attributable to Parent, Ending Balance | $ (14,127,322) | (14,127,322) | (13,749,276) | |||||||
Proceeds from Issuance or Sale of Equity, Total | 477,000 | 418,000 | $ 452,000 | |||||||
Payments of Stock Issuance Costs | 44,436 | $ 13,508 | ||||||||
Deferred Compensation Liability, Amount Cancelled | 2,404,000 | |||||||||
Minimum [Member] | ||||||||||
Capital Required for Capital Adequacy | 2,500,000 | |||||||||
Maximum [Member] | ||||||||||
Capital Required for Capital Adequacy | $ 50,000,000 | |||||||||
PA-1 [Member] | ||||||||||
Debt Instrument, Debt Default, Amount | $ 8,137,117 | |||||||||
Property, Plant and Equipment of PA1 [Member] | ||||||||||
Impairment of Long-Lived Assets Held-for-use | $ 0 | $ 1,684,562 | $ 3,750,000 |
Note 2 - Significant Accounti_3
Note 2 - Significant Accounting Policies (Details Textual) | 6 Months Ended |
Dec. 31, 2018 | |
Minimum [Member] | |
Property, Plant and Equipment, Useful Life | 3 years |
Maximum [Member] | |
Property, Plant and Equipment, Useful Life | 20 years |
Centerpoint [Member] | |
Noncontrolling Interest, Ownership Percentage by Parent | 58.90% |
Note 2 - Significant Accounti_4
Note 2 - Significant Accounting Policies - Antidilutive Securities (Details) - shares | 6 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Warrant [Member] | ||
Antidilutive securities (in shares) | 16,305,320 | 12,195,920 |
Employee Stock Option [Member] | ||
Antidilutive securities (in shares) | 7,152,225 | 4,840,037 |
Convertible Debt Securities [Member] | ||
Antidilutive securities (in shares) | 8,136,018 | 6,855,942 |
Convertible Preferred Stock Antidilutive Securities [Member] | ||
Antidilutive securities (in shares) | 17,500 | 16,500 |
Note 2 - Significant Accounti_5
Note 2 - Significant Accounting Policies - Earnings Per Share, Basic and Diluted (Details) - shares | 3 Months Ended | 6 Months Ended | ||||||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | Sep. 30, 2018 | Jun. 30, 2018 | Sep. 30, 2017 | Jun. 30, 2017 | |
Shares issued – beginning of period (in shares) | 27,121,371 | 27,121,371 | 26,996,148 | 25,939,892 | 24,809,841 | 24,748,213 | ||
Shares held by subsidiaries (Note 7) (in shares) | (704,309) | (704,309) | (704,309) | (704,309) | ||||
Shares outstanding – beginning of period (in shares) | 26,417,062 | 26,417,062 | 26,291,839 | 25,235,583 | 24,105,532 | 24,043,904 | ||
Weighted average shares issued during the period (in shares) | 90,939 | 127,591 | 785,681 | 106,204 | ||||
Diluted weighted average shares – end of period (in shares) | 26,382,778 | 24,233,123 | 26,021,264 | 24,150,108 |
Note 3 - Property and Equipme_3
Note 3 - Property and Equipment (Details Textual) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | Jun. 30, 2018 | |
Impairment of Long-Lived Assets Held-for-use | $ 1,684,562 | ||||||
Depreciation, Total | $ 259 | $ 436 | $ 695 | $ 872 | |||
Property, Plant and Equipment, Net, Ending Balance | $ 1,711 | 1,711 | $ 1,448 | ||||
Property, Plant and Equipment of PA1 [Member] | |||||||
Impairment of Long-Lived Assets Held-for-use | $ 0 | 1,684,562 | $ 3,750,000 | ||||
Property, Plant and Equipment, Net, Ending Balance | $ 0 |
Note 3 - Property and Equipme_4
Note 3 - Property and Equipment - Property and Equipment (Details) - USD ($) | Dec. 31, 2018 | Jun. 30, 2018 |
Machinery and equipment | $ 2,222,670 | $ 2,222,670 |
Buildings and structures | 401,470 | 401,470 |
Computers and office equipment | 171,720 | 171,613 |
Total | 2,795,860 | 2,795,753 |
Less accumulated depreciation | (2,794,149) | (2,794,305) |
Net | $ 1,711 | $ 1,448 |
Note 4 - Deferred Compensation
Note 4 - Deferred Compensation (Details Textual) - USD ($) | 3 Months Ended | 6 Months Ended | |||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | Jun. 30, 2018 | |
Deferred Compensation Liability, Current, Total | $ 698,766 | $ 141,284 | $ 698,766 | $ 141,284 | $ 421,641 |
Interest Rate on Deferred Compensation | 4.00% | 4.00% | |||
Deferred Compensation Conversion Days | 5 days | ||||
Deferred Compensation Consecutive Trading Days | 10 days | ||||
Interest Expense, Total | $ 97,304 | 93,662 | $ 189,800 | 192,101 | |
Interest Expense on Deferred Compensation Obligation [Member] | |||||
Interest Expense, Total | 8,388 | 31,055 | |||
Interest Expense, Related Party | 6,596 | 25,177 | |||
Chief Executive Officer [Member] | |||||
Deferred Compensation Liability, Current, Total | 396,041 | 31,000 | 396,041 | 31,000 | |
Deferred Compensation, Convertible to Common Stock | $ 300,000 | $ 300,000 | |||
Deferred Compensation, Convertible to Common Stock, Price Per Share | $ 0.75 | $ 0.75 | |||
President [Member] | |||||
Deferred Compensation Liability, Current, Total | $ 42,541 | 18,000 | $ 42,541 | 18,000 | |
Deferred Compensation, Convertible to Common Stock | $ 300,000 | $ 300,000 | |||
Deferred Compensation, Convertible to Common Stock, Price Per Share | $ 0.75 | $ 0.75 | |||
Consultants [Member] | |||||
Deferred Compensation Liability, Current, Total | $ 186,700 | $ 18,800 | $ 186,700 | $ 18,800 | |
Interest Rate on Deferred Compensation | 3.00% | 3.00% | |||
Individual Employee [Member] | |||||
Deferred Compensation Liability, Current, Total | $ 984 | $ 984 | |||
Deferred Compensation Shares Issued upon Conversion | 1,427 | ||||
Former Employee [Member] | |||||
Deferred Compensation Liability, Current, Total | $ 72,500 | $ 72,500 |
Note 5 - Loan Payable (Details
Note 5 - Loan Payable (Details Textual) - USD ($) | 3 Months Ended | 6 Months Ended | 72 Months Ended | ||||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2018 | Sep. 25, 2014 | Jan. 26, 2009 | |
Construction Loan | $ 7,750,000 | ||||||
PA-1 [Member] | |||||||
Debt Instrument, Debt Default, Amount | $ 8,137,117 | ||||||
Pennvest Loan [Member] | |||||||
Construction Loan | $ 9,160,313 | $ 9,160,313 | $ 9,160,313 | ||||
Accrued Interest and Late Charges Payable | 1,406,313 | 1,406,313 | 1,406,313 | ||||
Line of Credit Facility, Maximum Borrowing Capacity | 7,754,000 | $ 7,754,000 | 7,754,000 | ||||
Term Loan, Period for Interest Only Payments | 3 years | ||||||
Term Loan, Period for Amortization of Principal | 10 years | ||||||
Repayments of Long-term Debt, Total | 3,502,000 | ||||||
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months | 771,000 | $ 771,000 | 771,000 | ||||
Long-term Debt, Maturities, Repayments of Principal in Year Two | 794,000 | 794,000 | 794,000 | ||||
Long-term Debt, Maturities, Repayments of Principal in Year Three | 819,000 | 819,000 | 819,000 | ||||
Long-term Debt, Maturities, Repayments of Principal in Year Four | 846,000 | 846,000 | 846,000 | ||||
Long-term Debt, Maturities, Repayments of Principal in Year Five | 873,000 | 873,000 | 873,000 | ||||
Long-term Debt, Maturities, Repayments of Principal after Year Five | 149,000 | 149,000 | $ 149,000 | ||||
Interest Expense, Debt, Total | $ 60,408 | $ 49,373 | $ 113,747 | $ 98,747 | |||
Pennvest Loan [Member] | Years One Through Five [Member] | |||||||
Debt Instrument, Interest Rate During Period | 2.547% | ||||||
Pennvest Loan [Member] | Years Six Through Maturity [Member] | |||||||
Debt Instrument, Interest Rate During Period | 3.184% |
Note 6 - Convertible Notes Pa_2
Note 6 - Convertible Notes Payable - Affiliates (Details Textual) - USD ($) | 3 Months Ended | 6 Months Ended | |||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | Jun. 30, 2016 | |
Interest Expense, Total | $ 97,304 | $ 93,662 | $ 189,800 | $ 192,101 | |
Warrants Payable With Secured Promissory Notes [Member] | |||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.60 | $ 0.60 | |||
Class of Warrant or Right, Purchase Price of Warrants or Rights, Per Share | $ 0.10 | $ 0.10 | |||
Chief Executive Officer [Member] | Warrants Payable With Secured Promissory Notes [Member] | |||||
Class of Warrant or Right, Number Agreed to Sell | 3,000,000 | ||||
President [Member] | |||||
Number of Shares Per Unit | 1 | 1 | |||
Number of Warrants Per Unit | 1 | 1 | |||
President [Member] | Warrants Payable With Secured Promissory Notes [Member] | |||||
Class of Warrant or Right, Number Agreed to Sell | 300,000 | ||||
January 2015 Convertible Notes [Member] | Chief Executive Officer [Member] | Warrants Payable With Secured Promissory Notes [Member] | |||||
Secured Promissory Notes Payable with Warrants | $ 300,000 | $ 300,000 | |||
January 2015 Convertible Notes [Member] | President [Member] | Warrants Payable With Secured Promissory Notes [Member] | |||||
Secured Promissory Notes Payable with Warrants | $ 30,000 | $ 30,000 | |||
January 2015 Convertible Notes [Member] | Convertible Debt [Member] | |||||
Debt Instrument, Interest Rate, Stated Percentage | 4.00% | 4.00% | |||
Number of Shares Per Unit | 1 | 1 | |||
Number of Warrants Per Unit | 0.5 | 0.5 | |||
Conversion Price Per Unit | $ 0.50 | $ 0.50 | |||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 1 | $ 1 | |||
Debt Instrument, Convertible, Beneficial Conversion Feature | $ 0 | ||||
Interest Expense, Total | $ 26,247 | 26,247 | 52,495 | 52,495 | |
January 2015 Convertible Notes [Member] | Convertible Debt [Member] | Chief Executive Officer [Member] | |||||
Convertible Notes Payable, Noncurrent | 1,698,873 | 1,640,291 | 1,698,873 | 1,640,291 | |
January 2015 Convertible Notes [Member] | Convertible Debt [Member] | President [Member] | |||||
Convertible Notes Payable, Noncurrent | 882,202 | 851,781 | 882,202 | 851,781 | |
January 2015 Convertible Notes [Member] | Convertible Debt [Member] | Executive Vice Chairman [Member] | |||||
Convertible Notes Payable, Noncurrent | 438,816 | 423,685 | 438,816 | 423,685 | |
September 2015 Convertible Notes [Member] | Chief Executive Officer [Member] | |||||
Convertible Notes Payable, Total | 157,141 | 443,627 | 157,141 | 443,627 | $ 405,831 |
September 2015 Convertible Notes [Member] | Executive Vice Chairman [Member] | |||||
Convertible Notes Payable, Total | 18,554 | 17,899 | 18,554 | 17,899 | 82,921 |
September 2015 Convertible Notes [Member] | Chief Financial Officer [Member] | |||||
Convertible Notes Payable, Total | $ 16,382 | ||||
September 2015 Convertible Notes [Member] | Shareholder [Member] | |||||
Convertible Notes Payable, Total | $ 392,544 | 90,600 | $ 392,544 | 90,600 | |
September 2015 Convertible Notes [Member] | Convertible Debt [Member] | |||||
Debt Instrument, Interest Rate, Stated Percentage | 4.00% | 4.00% | |||
Conversion Price Per Unit | $ 0.60 | $ 0.60 | |||
Debt Instrument, Convertible, Beneficial Conversion Feature | $ 0 | ||||
Interest Expense, Total | $ 5,410 | $ 5,308 | 10,420 | $ 10,401 | |
Replacement Note Held as Collateral [Member] | Chief Executive Officer [Member] | |||||
Convertible Notes Payable, Total | $ 130,000 | 130,000 | |||
Convertible Debt, Amount Sold to a Shareholder By an Officer | $ 300,000 |
Note 7 - Stockholders' Equity_2
Note 7 - Stockholders' Equity (Details Textual) | Jul. 01, 2014$ / sharesshares | Dec. 31, 2018USD ($)$ / sharesshares | Dec. 31, 2017USD ($)shares | Dec. 31, 2018USD ($)$ / sharesshares | Dec. 31, 2017USD ($)shares | Jun. 30, 2018USD ($)$ / sharesshares | Jun. 30, 2017USD ($) | Sep. 30, 2018shares | Aug. 01, 2018USD ($)$ / sharesshares |
Common Stock Voting Rights Votes Per Share | 1 | ||||||||
Shares Held by Subsidiaries | 704,309 | 704,309 | 704,309 | 704,309 | |||||
Stock Issued During Period, Value, Issued for Services | $ | $ 13,904 | ||||||||
Stock Issued During Period, Shares, CommissionsOnSaleOfUnits | 1,028 | ||||||||
Shares Issued for Warrant Exercise Commissions | $ | $ 514 | ||||||||
Proceeds from the Sale of Units | $ | 477,365 | 186,832 | |||||||
Adjustments to Additional Paid in Capital, Warrant Issued | $ | $ 6,250 | ||||||||
Class of Warrant or Right, Outstanding | 16,300,000 | 16,300,000 | |||||||
Weighted Average Exercise Price for Outstanding Warrants | $ / shares | $ 0.96 | ||||||||
Weighted Average Remaining Contractual Life for Outstanding Warrants | 4 years 36 days | ||||||||
Class of Warrant or Right, Number for Which Expiration Date Extended | 5,079,188 | ||||||||
Modification of Warrants | $ | $ 163,026 | ||||||||
Interest Expense Related to the Modification of Warrants | $ | $ 3,750 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 325,000 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | $ | $ 80,500 | ||||||||
Expired [Member] | |||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 1 | $ 1 | |||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 41,319 | 41,319 | |||||||
Employee Stock Option [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 30,000,000 | 30,000,000 | |||||||
Allocated Share-based Compensation Expense, Total | $ | $ 22,500 | $ 97,350 | $ 118,000 | $ 99,650 | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 325,000 | 295,000 | |||||||
Subscription Agreement [Member] | |||||||||
Share Price | $ / shares | $ 0.75 | $ 0.75 | |||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 0.50 | $ 0.50 | |||||||
Number of Warrants Per Unit | 1 | 1 | |||||||
Sale of Units, Number Of Units Issued | 954,733 | ||||||||
Proceeds from the Sale of Units | $ | $ 477,365 | ||||||||
Proceeds from Sale of Units, Net of Commissions | $ | $ 432,929 | ||||||||
Stock Issued During Period, Shares, New Issues | 954,733 | ||||||||
Class of Warrant or Right, Issued During Period | 477,369 | ||||||||
Warrant Fair Value Price Per Share | $ / shares | $ 0.05 | $ 0.05 | |||||||
Adjustments to Additional Paid in Capital, Warrant Issued | $ | $ 17,515 | ||||||||
Adjustments to Additional Paid in Capital, Other | $ | $ 459,850 | ||||||||
Subscription Agreement [Member] | Restricted Stock [Member] | |||||||||
Number of Shares Per Unit | 1 | 1 | |||||||
Minimum [Member] | |||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 0.60 | $ 0.60 | |||||||
Maximum [Member] | |||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | 3 | $ 3 | |||||||
Maximum [Member] | Employee Stock Option [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 10 years | ||||||||
Employees and Consultants [Member] | |||||||||
Stock Issued During Period, Shares, Issued for Services | 25,718 | ||||||||
Stock Issued During Period, Value, Issued for Services | $ | $ 13,904 | ||||||||
Employees and Consultants [Member] | Minimum [Member] | |||||||||
Share Price | $ / shares | 0.50 | $ 0.50 | |||||||
Employees and Consultants [Member] | Maximum [Member] | |||||||||
Share Price | $ / shares | $ 0.74 | $ 0.74 | |||||||
President [Member] | |||||||||
Number of Shares Per Unit | 1 | 1 | |||||||
Number of Warrants Per Unit | 1 | 1 | |||||||
Deferred Compensation, Converted to Units, Amount | $ | $ 87,063 | ||||||||
Accounts Payable, Converted to Units, Amount | $ | $ 12,937 | ||||||||
Deferred Compensation and Accounts Payable Converted to Units, Shares | 200,000 | ||||||||
Deferred Compensation, Loan Payable, and Accounts Payable Converted to Units, Price Per Unit | $ / shares | $ 0.50 | $ 0.50 | |||||||
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | 0.5 | 0.5 | |||||||
Class of Warrant or Right, Number for Which Expiration Date Extended | 3,104,010 | ||||||||
Modification of Warrants | $ | $ 68,758 | ||||||||
President [Member] | Secured Promissory Note, Consideration for Warrants Expiring on December 31, 2023 [Member] | |||||||||
Financing Receivable, Net, Total | $ | $ 30,000 | $ 30,000 | |||||||
Financing Receivable, Interest Rate, Stated Percentage | 4.00% | 4.00% | |||||||
President [Member] | Warrants Related to the Conversion of Deferred Compensation and Accounts Payable into Units [Member] | |||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 0.75 | $ 0.75 | |||||||
President [Member] | Warrants Expiring on December 31, 2023 [Member] | |||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 0.60 | $ 0.60 | |||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 300,000 | 300,000 | |||||||
Execution Bonus as Percentage of Exercised Options and Warrants | 75.00% | 75.00% | |||||||
President [Member] | Employee Stock Option [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Incremental Compensation Cost | $ | $ 222,300 | ||||||||
Chief Executive Officer [Member] | |||||||||
Class of Warrant or Right, Number for Which Expiration Date Extended | 1,765,000 | ||||||||
Modification of Warrants | $ | $ 88,250 | ||||||||
Chief Executive Officer [Member] | Secured Promissory Note, Consideration for Warrants Expiring on December 31, 2025 [Member] | |||||||||
Financing Receivable, Net, Total | $ | $ 300,000 | $ 300,000 | $ 300,000 | ||||||
Financing Receivable, Interest Rate, Stated Percentage | 4.00% | 4.00% | |||||||
Chief Executive Officer [Member] | Warrants Expiring on December 31, 2025 [Member] | |||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 0.60 | $ 0.60 | $ 0.60 | ||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 3,000,000 | 3,000,000 | 3,000,000 | ||||||
Consultant [Member] | |||||||||
Class of Warrant or Right, Issued During Period | 125,000 | ||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 125,000 | 125,000 | |||||||
Class of Warrant or Right, Issued During the Period, Value Issued for Expenses | $ | $ 6,250 | ||||||||
Consultant [Member] | Minimum [Member] | |||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 0.74 | $ 0.74 | |||||||
Consultant [Member] | Maximum [Member] | |||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 1.20 | $ 1.20 | |||||||
Centerpoint [Member] | |||||||||
Shares Held by Subsidiaries | 704,309 | ||||||||
Series B Preferred Stock [Member] | |||||||||
Preferred Stock, Shares Outstanding, Ending Balance | 200 | 200 | 200 | 200 | |||||
Preferred Stock, Par or Stated Value Per Share | $ / shares | $ 0.01 | $ 0.01 | $ 0.01 | $ 0.01 | |||||
Preferred Stock, Convertible Option Per Share | $ / shares | $ 2 | ||||||||
Preferred Stock, Dividend Rate, Percentage | 2.50% | ||||||||
Preferred Stock, Redemption Price Per Share | $ / shares | $ 100 | ||||||||
Convertible Preferred Stock Redemption Period | 3 years | ||||||||
Dividends, Preferred Stock, Total | $ | $ 1,000 | $ 2,000 | $ 2,000 | ||||||
Dividends Payable | $ | $ 15,000 | $ 15,000 |
Note 7 - Stockholders' Equity -
Note 7 - Stockholders' Equity - Black-scholes Valuation Assumptions for Options (Details) - Employee Stock Option [Member] | 6 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Volatility | 73.00% | |
Risk-free interest rate | 1.75% | |
Expected term (Year) | 3 years | |
Weighted Average [Member] | ||
Volatility | 70.00% | 73.00% |
Risk-free interest rate | 2.73% | 1.75% |
Expected term (Year) | 3 years 328 days | 3 years |
Minimum [Member] | ||
Volatility | 63.00% | |
Risk-free interest rate | 2.68% | |
Expected term (Year) | 3 years 146 days | |
Maximum [Member] | ||
Volatility | 76.00% | |
Risk-free interest rate | 2.78% | |
Expected term (Year) | 4 years 109 days |
Note 7 - Stockholders' Equity_3
Note 7 - Stockholders' Equity - Stock Options Activity (Details) - USD ($) | 6 Months Ended | 12 Months Ended |
Dec. 31, 2018 | Jun. 30, 2018 | |
Outstanding (in shares) | 6,827,225 | |
Outstanding, weighted-average exercise price (in dollars per share) | $ 1.11 | |
Outstanding, weighted-average remaining contractual life (Year) | 3 years 182 days | 3 years 292 days |
Granted, options (in shares) | 325,000 | |
Granted, weighted-average exercise price (in dollars per share) | $ 0.68 | |
Exercised, options (in shares) | ||
Exercised, weighted-average exercise price (in dollars per share) | ||
Forfeited, options (in shares) | ||
Forfeited, weighted-average exercise price (in dollars per share) | ||
Expired, options (in shares) | ||
Expired, weighted-average exercise price (in dollars per share) | ||
Outstanding (in shares) | 7,152,225 | 6,827,225 |
Outstanding, weighted-average exercise price (in dollars per share) | $ 1.10 | $ 1.11 |
Outstanding, aggregate intrinsic value | $ 36,675 | |
Exercisable, options (in shares) | 7,002,225 | |
Exercisable, weighted-average exercise price (in dollars per share) | $ 1.11 | |
Exercisable, weighted-average remaining contractual life (Year) | 3 years 219 days | |
Exercisable, aggregate intrinsic value | $ 23,175 |
Note 7 - Stockholders' Equity_4
Note 7 - Stockholders' Equity - Nonvested Share Activity (Details) | 6 Months Ended |
Dec. 31, 2018$ / sharesshares | |
Nonvested (in shares) | shares | |
Nonvested, weighted-average grant-date fair value (in dollars per share) | $ / shares | |
Granted, options (in shares) | shares | 325,000 |
Granted, weighted-average grant-date fair value (in dollars per share) | $ / shares | $ 0.36 |
Vested (in shares) | shares | (175,000) |
Vested, weighted-average grant-date fair value (in dollars per share) | $ / shares | $ 0.46 |
Nonvested (in shares) | shares | 150,000 |
Nonvested, weighted-average grant-date fair value (in dollars per share) | $ / shares | $ 0.25 |
Note 7 - Stockholders' Equity_5
Note 7 - Stockholders' Equity - Allocation of Recognized Period Costs (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | |
Employee Stock Option [Member] | ||||
Allocated Share-based Compensation Expense | $ 22,500 | $ 97,350 | $ 118,000 | $ 99,650 |
General and Administrative Expense [Member] | ||||
Allocated Share-based Compensation Expense | 22,500 | 501,066 | 421,543 | 507,499 |
Change in fair value from modification of warrant terms | 156,865 | 118,233 | 156,865 | |
General and Administrative Expense [Member] | Stock Bonus [Member] | ||||
Allocated Share-based Compensation Expense | 3,090 | 7,223 | ||
General and Administrative Expense [Member] | Employee Stock Option [Member] | ||||
Allocated Share-based Compensation Expense | 22,500 | 97,350 | 92,125 | 99,650 |
Change in fair value from modification of option terms | 243,761 | 211,185 | 243,761 | |
Research and Development Expense [Member] | ||||
Allocated Share-based Compensation Expense | 246,643 | 81,783 | 253,670 | |
Change in fair value from modification of warrant terms | 132,677 | 44,793 | 132,677 | |
Research and Development Expense [Member] | Stock Bonus [Member] | ||||
Allocated Share-based Compensation Expense | 8,071 | 15,098 | ||
Research and Development Expense [Member] | Employee Stock Option [Member] | ||||
Allocated Share-based Compensation Expense | 25,875 | |||
Change in fair value from modification of option terms | $ 105,895 | $ 11,115 | $ 105,895 |
Note 8 - Commitments and Cont_2
Note 8 - Commitments and Contingencies (Details Textual) - USD ($) | Oct. 10, 2016 | Sep. 25, 2014 | May 15, 2013 | Feb. 28, 2018 | Dec. 31, 2018 | Aug. 01, 2018 | Jun. 30, 2018 | Jun. 30, 2017 | Apr. 27, 2017 | Oct. 31, 2016 | Jun. 30, 2014 |
Extension of Exercise Period Annual Payment per Option or Warrant | $ 0.05 | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance | 7,152,225 | 6,827,225 | |||||||||
Class of Warrant or Right, Outstanding | 16,300,000 | ||||||||||
Pennvest Loan [Member] | |||||||||||
Loss Contingency, Damages Sought, Value | $ 8,137,117 | ||||||||||
Minimum [Member] | |||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.60 | ||||||||||
Maximum [Member] | |||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 3 | ||||||||||
Exercise Bonus [Member] | |||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance | 6,959,600 | ||||||||||
Class of Warrant or Right, Outstanding | 12,032,095 | ||||||||||
Exercise Bonus [Member] | Minimum [Member] | |||||||||||
Execution Bonus as Percentage of Exercised Options and Warrants | 50.00% | ||||||||||
Exercise Bonus [Member] | Maximum [Member] | |||||||||||
Execution Bonus as Percentage of Exercised Options and Warrants | 90.00% | ||||||||||
President [Member] | |||||||||||
Monthly Officers' Cash Compensation | $ 18,000 | ||||||||||
President [Member] | FY2016 Extension Agreement [Member] | Extension Bonus [Member] | |||||||||||
Deferred Compensation, Maximum Convertible Amount | $ 125,000 | $ 300,000 | $ 125,000 | ||||||||
Deferred Compensation, Stock Conversion, Price Per Share | $ 0.75 | $ 0.75 | $ 0.75 | ||||||||
President [Member] | February 2018 Extension Agreement [Member] | Extension Bonus [Member] | |||||||||||
Annual Salary | $ 372,000 | ||||||||||
Monthly Compensation, Life Insurance | $ 2,000 | ||||||||||
Chief Executive Officer [Member] | |||||||||||
Monthly Officers' Cash Compensation | $ 31,000 | ||||||||||
Chief Executive Officer [Member] | Warrants Expiring on December 31, 2025 [Member] | |||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 3,000,000 | 3,000,000 | |||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.60 | $ 0.60 | |||||||||
Chief Executive Officer [Member] | Secured Promissory Note, Consideration for Warrants Expiring on December 31, 2025 [Member] | |||||||||||
Financing Receivable, Net, Total | $ 300,000 | $ 300,000 | |||||||||
Note Receivable, Collateral | $ 300,000 | ||||||||||
Chief Executive Officer [Member] | Stock Bonus [Member] | |||||||||||
Execution Bonus as Percentage of Exercised Options and Warrants | 50.00% | ||||||||||
Chief Executive Officer [Member] | FY2016 Extension Agreement [Member] | Extension Bonus [Member] | |||||||||||
Deferred Compensation, Maximum Convertible Amount | $ 300,000 | ||||||||||
Deferred Compensation, Stock Conversion, Price Per Share | $ 0.75 | ||||||||||
CEO and President [Member] | Exercise Bonus [Member] | |||||||||||
ContingentStockBonusPercentageThresholdForIssuance | 50.00% | ||||||||||
Extension of Exercise Period | 5 years | ||||||||||
Extension of Exercise Period Annual Payment per Option or Warrant | $ 0.01 | ||||||||||
Executive Vice Chairman and Other Board Member [Member] | Exercise Bonus [Member] | |||||||||||
Execution Bonus as Percentage of Exercised Options and Warrants | 50.00% | ||||||||||
Two Former Employees [Member] | Exercise Bonus [Member] | |||||||||||
Execution Bonus as Percentage of Exercised Options and Warrants | 50.00% | ||||||||||
CEO, President, and Executive Vice Chairman [Member] | Exercise Bonus [Member] | |||||||||||
Execution Bonus as Percentage of Exercised Options and Warrants | 75.00% | 50.00% |
Note 9 - Related Party Transa_2
Note 9 - Related Party Transactions (Details Textual) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | Jun. 30, 2018 | Jun. 30, 2017 | |
Stock Issued During Period, Value, Issued for Services | $ 13,904 | |||||
Coalition for Affordable Bay Solutions [Member] | ||||||
Related Party Transaction, Expenses from Transactions with Related Party | $ 165,650 | |||||
Related Party Transaction, Contributions | $ 68,900 | |||||
Stock Issued During Period, Shares, Issued for Services | 16,000 | 129,000 | ||||
Stock Issued During Period, Value, Issued for Services | $ 8,000 | $ 96,750 | ||||
Related Party Transaction, Reimbursements | $ 0 | $ 0 | $ 30,000 | $ 0 | $ 41,000 |
Note 10 - Subsequent Events (De
Note 10 - Subsequent Events (Details Textual) - USD ($) | 1 Months Ended | 6 Months Ended |
Feb. 06, 2019 | Dec. 31, 2018 | |
Stock Issued During Period, Value, Issued for Services | $ 13,904 | |
Sale of Units, Value | $ 477,365 | |
Subsequent Event [Member] | ||
Stock Issued During Period, Shares, Issued for Services | 2,918 | |
Stock Issued During Period, Value, Issued for Services | $ 2,000 | |
Sale of Units, Number Of Units Issued | 400,000 | |
Shares Issued, Price Per Share | $ 0.50 | |
Sale of Units, Value | $ 200,000 | |
Number of Shares Per Unit | 1 | |
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.75 | |
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | 0.5 |